After positive discussions with US regulators concerning the filing of omidubicel, Israel's Gamida Cell Ltd. is now looking for partners to commercialize the umbilical cord blood-derived cell therapy for patients with blood cancers in need of a stem cell transplant.
Gamida Cell Gears Up For Omidubicel Submission
Seeks Partners For Bone Marrow Transplant Cell Therapy
With funding drying up for biotechs as sentiment continues to turn against the sector, Israel-headquartered Gamida Cell is cutting jobs and putting out feelers for potential partners to take its promising cell therapy to market.
